Loading
Loading
Your feedback directly shapes Sporos.
Sign in to track your feedback history
Requires health plans that provide prescription benefits to cover at least one type of glucagon auto-injector, nasal spray, or formulation that does not require reconstitution to treat hypoglycemia. No copayment or deductible would be required.
Introduced
Jan 24, 2025
Last Action
Mar 6, 2025
Session
RI 2025
Sponsors
10 primary · 0 co
03/06/2025 Committee recommended measure be held for further study
02/28/2025 Scheduled for hearing and/or consideration (03/06/2025)
01/24/2025 Introduced, referred to House Health & Human Services